Cipia (TASE:CPIA), a computer vision AI in-cabin automotive solutions provider, today announced an expansion of the company’s existing partnership with Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor and software company.
RallyBio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company, today announced that it has obtained worldwide exclusive rights to Sanofi’s KY1066, a preclinical potentially first-in-class antibody.
ENSEM Therapeutics Raises $67 Million in Series A Financing to Develop Small Molecule Medicines for Difficult-to-Drug Targets.
ENSEM Therapeutics Inc. (ENSEM), a Boston-based biotechnology company focusing on high value and difficult-to-drug oncology targets, announced today the closing of a series A2 financing.
Cipia today announced that the company was awarded two new models with a leading Chinese OEM.